THAP7 and cholangiocarcinoma: In contrast, decreased THAP7-AS1 and AC090772.1 expression implied a worse survival time in CCA patients (log-rank p-value = 0.041 Fig. 5B, log-rank p-value = 0.025 Fig. 5C).